Literature DB >> 21773873

Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society's Multidisciplinary Consensus Conference.

Michael N Diringer1, Thomas P Bleck, J Claude Hemphill, David Menon, Lori Shutter, Paul Vespa, Nicolas Bruder, E Sander Connolly, Giuseppe Citerio, Daryl Gress, Daniel Hänggi, Brian L Hoh, Giuseppe Lanzino, Peter Le Roux, Alejandro Rabinstein, Erich Schmutzhard, Nino Stocchetti, Jose I Suarez, Miriam Treggiari, Ming-Yuan Tseng, Mervyn D I Vergouwen, Stefan Wolf, Gregory Zipfel.   

Abstract

Subarachnoid hemorrhage (SAH) is an acute cerebrovascular event which can have devastating effects on the central nervous system as well as a profound impact on several other organs. SAH patients are routinely admitted to an intensive care unit and are cared for by a multidisciplinary team. A lack of high quality data has led to numerous approaches to management and limited guidance on choosing among them. Existing guidelines emphasize risk factors, prevention, natural history, and prevention of rebleeding, but provide limited discussion of the complex critical care issues involved in the care of SAH patients. The Neurocritical Care Society organized an international, multidisciplinary consensus conference on the critical care management of SAH to address this need. Experts from neurocritical care, neurosurgery, neurology, interventional neuroradiology, and neuroanesthesiology from Europe and North America were recruited based on their publications and expertise. A jury of four experienced neurointensivists was selected for their experience in clinical investigations and development of practice guidelines. Recommendations were developed based on literature review using the GRADE system, discussion integrating the literature with the collective experience of the participants and critical review by an impartial jury. Recommendations were developed using the GRADE system. Emphasis was placed on the principle that recommendations should be based not only on the quality of the data but also tradeoffs and translation into practice. Strong consideration was given to providing guidance and recommendations for all issues faced in the daily management of SAH patients, even in the absence of high quality data.

Entities:  

Mesh:

Year:  2011        PMID: 21773873     DOI: 10.1007/s12028-011-9605-9

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  194 in total

Review 1.  Action of magnesium sulfate in the treatment of preeclampsia-eclampsia.

Authors:  M Sadeh
Journal:  Stroke       Date:  1989-09       Impact factor: 7.914

2.  Prophylactic intravenous magnesium sulfate for treatment of aneurysmal subarachnoid hemorrhage: a randomized, placebo-controlled, clinical study.

Authors:  Thomas Westermaier; Christian Stetter; Giles H Vince; Mirko Pham; Jose Perez Tejon; Jörg Eriskat; Ekkehard Kunze; Cordula Matthies; Ralf-Ingo Ernestus; Laszlo Solymosi; Klaus Roosen
Journal:  Crit Care Med       Date:  2010-05       Impact factor: 7.598

3.  Prognostic significance of hypernatremia and hyponatremia among patients with aneurysmal subarachnoid hemorrhage.

Authors:  Adnan I Qureshi; M Fareed K Suri; Gene Y Sung; Robert N Straw; Abutaher M Yahia; Mustafa Saad; Lee R Guterman; L Nelson Hopkins
Journal:  Neurosurgery       Date:  2002-04       Impact factor: 4.654

4.  High incidence of neuroendocrine dysfunction in long-term survivors of aneurysmal subarachnoid hemorrhage.

Authors:  Ioanna Dimopoulou; Andreas T Kouyialis; Marinella Tzanella; Apostolos Armaganidis; Nikolaos Thalassinos; Damianos E Sakas; Stylianos Tsagarakis
Journal:  Stroke       Date:  2004-10-21       Impact factor: 7.914

5.  Systemic glucose and brain energy metabolism after subarachnoid hemorrhage.

Authors:  Raimund Helbok; J Michael Schmidt; Pedro Kurtz; Khalid A Hanafy; Luis Fernandez; R Morgan Stuart; Mary Presciutti; Noeleen D Ostapkovich; E Sander Connolly; Kiwon Lee; Neeraj Badjatia; Stephan A Mayer; Jan Claassen
Journal:  Neurocrit Care       Date:  2010-06       Impact factor: 3.210

6.  Ultra-early rebleeding within six hours after aneurysmal rupture.

Authors:  T Inagawa
Journal:  Surg Neurol       Date:  1994-08

7.  Effect of prophylactic transluminal balloon angioplasty on cerebral vasospasm and outcome in patients with Fisher grade III subarachnoid hemorrhage: results of a phase II multicenter, randomized, clinical trial.

Authors:  Marike Zwienenberg-Lee; Jonathan Hartman; Nancy Rudisill; Lori Kennedy Madden; Karen Smith; Joseph Eskridge; David Newell; Bon Verweij; M Ross Bullock; Andrew Baker; William Coplin; Robert Mericle; Jian Dai; David Rocke; J Paul Muizelaar
Journal:  Stroke       Date:  2008-04-17       Impact factor: 7.914

8.  Fever burden and functional recovery after subarachnoid hemorrhage.

Authors:  Andrew M Naidech; Bernard R Bendok; Richard A Bernstein; Mark J Alberts; H Hunt Batjer; Charles M Watts; Thomas P Bleck
Journal:  Neurosurgery       Date:  2008-08       Impact factor: 4.654

9.  Mortality rates after subarachnoid hemorrhage: variations according to hospital case volume in 18 states.

Authors:  DeWitte T Cross; David L Tirschwell; Mary Ann Clark; Dan Tuden; Colin P Derdeyn; Christopher J Moran; Ralph G Dacey
Journal:  J Neurosurg       Date:  2003-11       Impact factor: 5.115

Review 10.  Rebleeding of ruptured cerebral aneurysms during three-dimensional computed tomographic angiography: report of two cases and literature review.

Authors:  Akihito Hashiguchi; Chikara Mimata; Homare Ichimura; Motohiro Morioka; Jun-ichi Kuratsu
Journal:  Neurosurg Rev       Date:  2007-02-16       Impact factor: 3.042

View more
  258 in total

Review 1.  Therapeutic hypothermia for acute neurological injuries.

Authors:  Lucia Rivera-Lara; Jiaying Zhang; Susanne Muehlschlegel
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

2.  The risks of blood transfusion in patients with subarachnoid hemorrhage.

Authors:  Paul E Marik
Journal:  Neurocrit Care       Date:  2012-04       Impact factor: 3.210

3.  Prevalence, timing, risk factors, and mechanisms of anterior cerebral artery infarctions following subarachnoid hemorrhage.

Authors:  Michael Moussouttas; Torrey Boland; Lily Chang; Ameesh Patel; Jaime McCourt; Mitchell Maltenfort
Journal:  J Neurol       Date:  2012-06-24       Impact factor: 4.849

4.  Effect of High-Dose Simvastatin on Cerebral Blood Flow and Static Autoregulation in Subarachnoid Hemorrhage.

Authors:  Michael N Diringer; Rajat Dhar; Michael Scalfani; Allyson R Zazulia; Michael Chicoine; William J Powers; Colin P Derdeyn
Journal:  Neurocrit Care       Date:  2016-08       Impact factor: 3.210

Review 5.  Delayed neurological deterioration after subarachnoid haemorrhage.

Authors:  R Loch Macdonald
Journal:  Nat Rev Neurol       Date:  2013-12-10       Impact factor: 42.937

6.  Benefit of second catheter angiography in patients with nontraumatic subarachnoidal hemorrhage.

Authors:  A Ringelstein; O Mueller; S L Goericke; C Moenninghoff; U Sure; I Wanke; M Forsting; M Schlamann
Journal:  Clin Neuroradiol       Date:  2013-11-28       Impact factor: 3.649

7.  Impact of hospital case-volume on subarachnoid hemorrhage outcomes: A nationwide analysis adjusting for hemorrhage severity.

Authors:  Barret Rush; Kali Romano; Mohammad Ashkanani; Robert C McDermid; Leo Anthony Celi
Journal:  J Crit Care       Date:  2016-09-14       Impact factor: 3.425

8.  Association of early post-procedure hemodynamic management with the outcomes of subarachnoid hemorrhage patients.

Authors:  Kazuaki Kuwabara; Kiyohide Fushimi; Shinya Matsuda; Koichi B Ishikawa; Hiromasa Horiguchi; Kenji Fujimori
Journal:  J Neurol       Date:  2012-10-25       Impact factor: 4.849

9.  Cranial Accelerometry Can Detect Cerebral Vasospasm Caused by Subarachnoid Hemorrhage.

Authors:  Wade S Smith; Janet L Browne; Nerissa U Ko
Journal:  Neurocrit Care       Date:  2015-12       Impact factor: 3.210

Review 10.  Aneurysmal Subarachnoid Hemorrhage.

Authors:  Athanasios K Petridis; Marcel A Kamp; Jan F Cornelius; Thomas Beez; Kerim Beseoglu; Bernd Turowski; Hans-Jakob Steiger
Journal:  Dtsch Arztebl Int       Date:  2017-03-31       Impact factor: 5.594

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.